ORIGINAL RESEARCH article
Front. Public Health
Sec. Public Mental Health
Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1596844
This article is part of the Research TopicBiomarkers of Response to Interventions in PsychiatryView all 3 articles
U-Shaped Association Between Myeloperoxidase Levels and Anxiety Risk: A Cross-Sectional Study in a Chinese Population
Provisionally accepted
- West China Hospital, Sichuan University, Chengdu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: This study investigates the association between myeloperoxidase (MPO) levels and anxiety risk in Chinese adults and explores potential effect modifiers, with implications for neuroinflammatory biomarker-guided anxiety prevention strategies.Using cross-sectional data from 30,418 adults undergoing routine health examinations (July 2020-June 2021), anxiety severity was assessed via the Self-Rating Anxiety Scale (SAS; score ≥50 as clinically relevant). Plasma MPO was quantified by ELISA. Multivariate logistic regression, restricted cubic splines (RCS), threshold effect analysis, and subgroup interactions were conducted to evaluate nonlinear associations.Results: A U-shaped relationship between MPO and anxiety risk was identified. In fully adjusted models, participants in the lowest (Q1: ≤29.77 ng/mL, OR=1.15, 95% CI:1.03-1.28, p=0.01) and highest quintiles (Q5: ≥47.3 ng/mL, OR=1.17, 95% CI: 1.05-1.31, p=0.004) exhibited significantly elevated anxiety risks compared to the reference quintile (Q2: 29.8-34.7 ng/mL). RCS analysis confirmed a nonlinear association (p for nonlinearity <0.01), with an inflection point at 30 ng/mL: below this threshold, each 1 ng/mL MPO increase reduced anxiety risk (OR=0.982, CI: 0.970-0.994), while levels above it heightened risk (OR=1.004, CI: 1.001-1.008). Diabetes mellitus significantly modified this relationship (p-interaction=0.028), with diabetic individuals showing amplified risks at higher plasma MPO (Q5 OR=1.84 vs. non-diabetic Q5 OR=1.15).: Plasma MPO demonstrates a U-shaped association with anxiety risk independent of cardiometabolic confounders. Diabetic individuals exhibit heightened susceptibility to MPO-related anxiety, suggesting synergistic neuroinflammatory pathways. Monitoring MPO may aid in risk stratification and personalized interventions, particularly in populations with diabetes.
Keywords: Myeloperoxidase, Anxiety, U-shaped association, Diabetes Mellitus, Cross-sectional study, Neuroinflammation
Received: 20 Mar 2025; Accepted: 18 Apr 2025.
Copyright: © 2025 Zhou, Kong, Liu and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xiaojing Liu, West China Hospital, Sichuan University, Chengdu, China
Yan Huang, West China Hospital, Sichuan University, Chengdu, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.